Company profile

Sunho Biologics

2898 · HKEX

Public Market Listing

2898HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Sunho Biologics are available on Yahoo Finance.

External market data link · No third-party exchange redistribution

Assets

(2 total)

2Total Assets

0Approved

0Phase 3 / Filed

2Phase 1–2 / Early

2Diseases

Showing 2 of 2 assets

		Target & Modality
IAP0971	Phase 1/2	PD-1 x IL-15/IL-15Rα complexSmall molecule	Non-Small Cell Lung Cancer
ISH0688	Phase 1	FGF21 receptorProtein / enzyme therapeutic	Atherosclerotic Cardiovascular Disease

Research

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Research

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.